Cas:10374-80-8 Dimethyl stilbene-4,4′-dicarboxylate manufacturer & supplier

We serve Chemical Name:Dimethyl stilbene-4,4′-dicarboxylate CAS:10374-80-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

Dimethyl stilbene-4,4'-dicarboxylate

Chemical Name:Dimethyl stilbene-4,4′-dicarboxylate
CAS.NO:10374-80-8
Synonyms:4,4′-Stilben-dicarbonsaeure-dimethylester;Stilben-4,4′-dicarbonsaeure-dimethylester;2,3-Diphenyl-but-2-en;dimethylstilbene-4,4′-dicarboxylate;stilbene-4,4′-dicarboxylic acid dimethyl ester;dimethyl 4,4′-stilbenedicarboxylate;2,3-diphenyl-but-2-ene;dimethylstilbene;2,3-Diphenyl-2-butene
Molecular Formula:C18H16O4
Molecular Weight:296.31700
HS Code:2916399090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:448.3ºC at 760 mmHg
Density:1.192g/cm3
Index of Refraction:1.619
PSA:52.60000
Exact Mass:296.10500
LogP:3.43020

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 4,4′-Stilben-dicarbonsaeure-dimethylester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,3-Diphenyl-2-butene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,3-Diphenyl-but-2-en Use and application,2,3-Diphenyl-but-2-en technical grade,usp/ep/jp grade.


Related News: The FDA said its decision allows for the J&J doses to be used in the United States or exported. T Dimethyl stilbene-4,4′-dicarboxylate manufacturer At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth. Dimethyl stilbene-4,4′-dicarboxylate supplier The FDA said its decision allows for the J&J doses to be used in the United States or exported. T Dimethyl stilbene-4,4′-dicarboxylate vendor Novavax, a Maryland biotechnology company that has struggled mightily with delays in developing its coronavirus vaccine, announced Monday that its two-shot regimen was over 90% effective overall in a trial that unfolded even as more contagious variants emerged. Dimethyl stilbene-4,4′-dicarboxylate factory The firm announced its own acquisition of California-based chemical, manufacturing and control (CMC) advisor Chamow & Associates back in January to bolster Alira’s biologics manufacturing, quality assurance and regulatory compliance business. Further yet, 12 months ago, Alira picked up French consulting firm Care Factory for its data science experts and electronic health record database knowledge.